The rise of degrader drugs

Mingxing Teng1, Nathanael S Gray2

  • 1Center for Drug Discovery, Department of Pathology & Immunology, and Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Cell Chemical Biology
|July 26, 2023
PubMed

Insights

Targeted protein degradation (TPD) offers a novel therapeutic approach by using small molecules to eliminate disease-causing proteins. This field is rapidly advancing, with numerous TPD drugs entering clinical trials for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Cancer genomics has identified numerous therapeutic targets.
  • Targeted protein degradation (TPD) is an emerging modality that hijacks cellular machinery to degrade proteins.
  • Over 20 TPD molecules targeting more than 12 proteins are in clinical development.

Purpose of the Study:

  • To provide a high-level evaluation of recent advancements in targeted protein degradation.
  • To discuss strategies for realizing the full therapeutic potential of TPD.
  • To highlight the potential for a "Gleevec moment" in TPD drug development.

Main Methods:

  • Review of current literature and clinical trial data in targeted protein degradation.
  • Analysis of the progress and challenges in developing novel protein degraders.
  • Evaluation of the clinical validation of TPD based on existing drug classes like IMiDs.

Main Results:

  • Significant progress in the rational design and development of TPD molecules.
  • Successful clinical entry of numerous TPD candidates.
  • Established precedent for TPD through immunomodulatory drugs (IMiDs) in multiple myeloma.

Conclusions:

  • The field of targeted protein degradation is rapidly maturing.
  • TPD holds significant promise as a new therapeutic modality for cancer treatment.
  • Further development and clinical validation are crucial to establish TPD's full potential.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.7K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
142
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
540